| Market Cap | 19M | P/E | 1.30 | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -1.78M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 11.00% |
| Sales | 203.72k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
| Dividend | N/A | Price/Book | 6.50 | EPS next 5Y | - | 52W High Chg | -41.00% |
| Recommedations | - | Quick Ratio | 3.14 | Shares Outstanding | 1.46B | 52W Low Chg | 53.00% |
| Insider Own | 3.64% | ROA | -48.49% | Shares Float | 1.41B | Beta | -0.35 |
| Inst Own | 0.05% | ROE | -97.70% | Shares Shorted/Prior | -/- | Price | 0.01 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 1,707,018 | Target Price | - |
| Oper. Margin | -14,189.22% | Earnings Date | May 13 | Volume | 3,062,284 | Change | 15.04% |
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves sleep product distributors, home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. The company is headquartered in Clearwater, Florida.
